Market Overview
According to Market Genics, the AI in Genomics Market is estimated to be valued at USD 0.6 Billion in 2025 and is projected to reach USD 6.5 Billion by 2035, registering a CAGR of 27.8% during the forecast period.
The market is experiencing significant growth as artificial intelligence becomes increasingly integrated into genomic research, precision medicine, drug discovery, and clinical diagnostics. AI technologies, including machine learning (ML), deep learning, natural language processing (NLP), and predictive analytics, are enabling researchers and healthcare professionals to analyze complex genomic datasets faster and more accurately than traditional methods.
The increasing adoption of next-generation sequencing (NGS), declining genome sequencing costs, rising prevalence of genetic disorders and cancer, and growing demand for personalized medicine are key factors accelerating market growth. AI-powered genomics platforms are transforming biomarker discovery, disease risk prediction, gene editing research, and precision therapeutics, making genomic analysis more scalable and efficient.
To obtain a free sample research report - https://marketgenics.co/download-report-sample/ai-in-genomics-market-89545?utm_source=Free&utm_medium=ruchika
Market Growth Drivers
Rising Adoption of Precision Medicine
Healthcare providers are increasingly leveraging AI-powered genomic analysis to develop personalized treatment plans based on an individual's genetic profile, improving clinical outcomes.
Growth in Next-Generation Sequencing (NGS)
The widespread use of next-generation sequencing technologies is generating massive genomic datasets that require AI-driven analytics for faster interpretation and actionable insights.
Increasing Prevalence of Genetic Disorders
The growing incidence of inherited diseases, rare genetic disorders, and cancer is driving demand for AI-enabled genomic diagnostics and predictive healthcare solutions.
Expanding Drug Discovery and Development
Pharmaceutical and biotechnology companies are utilizing AI to identify novel drug targets, accelerate biomarker discovery, and optimize clinical research processes.
Advancements in Machine Learning and Big Data Analytics
Continuous improvements in AI algorithms, cloud computing, and high-performance computing are enhancing the speed and accuracy of genomic data analysis.
Government and Research Investments
Increasing funding for genomic research, national genome sequencing initiatives, and AI-enabled healthcare innovation is supporting long-term market expansion.
Key Players
- Illumina Inc.
- Thermo Fisher Scientific
- NVIDIA Corporation
- Microsoft Corporation
- Google Health
- IBM Corporation
- Tempus AI
- SOPHiA GENETICS
- QIAGEN
- Oracle Health
- Fabric Genomics
- Deep Genomics
- BenevolentAI
- F. Hoffmann-La Roche Ltd.
- Agilent Technologies
Regional Insights
North America
North America dominates the AI in Genomics Market due to advanced genomic research infrastructure, significant investments in biotechnology, increasing adoption of precision medicine, and strong AI innovation.
Europe
Europe continues to witness steady market growth driven by government-supported genomic research programs, healthcare digitalization, and expanding precision medicine initiatives.
Asia-Pacific
Asia-Pacific is expected to register the fastest growth during the forecast period due to increasing healthcare investments, expanding biotechnology industries, growing genomic research programs, and rising AI adoption.
Latin America
Growing investments in genomic research, healthcare modernization, and biotechnology innovation are supporting market expansion across Brazil and Mexico.
Middle East & Africa
Healthcare digital transformation, increasing genomic research collaborations, and government initiatives are gradually driving AI adoption in genomics across the region.
Future Outlook
The AI in Genomics Market is expected to experience robust growth through 2035 as artificial intelligence continues to transform genomic research and precision healthcare.
Key trends shaping the future include:
- AI-powered genome sequencing analysis
- Precision medicine and personalized therapeutics
- Predictive genetic disease risk assessment
- AI-assisted biomarker discovery
- CRISPR and gene-editing optimization
- Multi-omics data integration
- Cloud-based genomic analytics platforms
- Federated AI for genomic research
- Rare disease diagnostics using AI
- Generative AI for genomic data interpretation
Growing collaboration between healthcare providers, biotechnology companies, pharmaceutical organizations, and research institutions is expected to accelerate innovation in genomic medicine. As sequencing technologies become more affordable and AI algorithms continue to evolve, AI-driven genomics solutions will play a critical role in advancing disease prevention, early diagnosis, targeted therapies, and precision healthcare worldwide.
Related Reports:
